Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Verschueren

Showing results (31-40 of 155) with videos related to

Pageof 16
Sort By:
Lancet (London, England)|May 31, 2011
PAS-positive macrophages--not always infectionWouter Meersseman, Patrick Verschueren, Thomas Tousseyn, et al.
Rheumatology (Oxford, England)|November 8, 2015
Non-infective endocarditis with systemic embolization and recurrent stroke in systemic sclerosisEllen De Langhe, Alexandra Seghers, Philippe Demaerel, et al.
Clinical Rheumatology|March 7, 2007
Development of sarcoidosis in etanercept-treated rheumatoid arthritis patientsKilian Verschueren, Els Van Essche, Patrick Verschueren, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 20, 2024
Integrating pretest probability for rheumatoid arthritis with likelihood ratios of RF and ACPA to improve clinical utility of rheumatoid arthritis autoantibody testingDaphné Vandebeek, Elke Lodewijckx, Lieve Van Hoovels, et al.
Joint Bone Spine|January 23, 2023
The future of polymyalgia rheumatica research: What can we learn from rheumatoid arthritis?Lien Moreel, Michaël Doumen, Albrecht Betrains, et al.
Clinical and Experimental Rheumatology|December 4, 2013
Anti-TNF therapy and malignancy in spondyloarthritis in the Leuven spondyloarthritis biologics cohort (BIOSPAR)Ine Westhovens, Rik J Lories, Rene Westhovens, et al.
Expert Opinion on Pharmacotherapy|June 11, 2015
The optimal combination therapy for the treatment of early rheumatoid arthritisDiederik De Cock, Kristien Van der Elst, Sabrina Meyfroidt, et al.
Best Practice & Research. Clinical Rheumatology|September 19, 2006
Contemporary concepts of inflammation, damage and repair in rheumatic diseasesFrank P Luyten, Rik J U Lories, Patrick Verschueren, et al.
Clinical Chemistry and Laboratory Medicine|November 15, 2013
Value-added reporting of antinuclear antibody testing by automated indirect immunofluorescence analysisSofie Schouwers, Myriam Bonnet, Patrick Verschueren, et al.
RMD Open|March 13, 2026
Autoantibody biomarkers and first-line therapy response in RA: findings from the CAP48 cohortSukayna Fadlallah, Judith Fraussen, Pieter Ruytinx, et al.
Pageof 16

Showing results (31-40 of 155) with videos related to

Sort By:
Pageof 16
Lancet (London, England)|May 31, 2011
PAS-positive macrophages--not always infectionWouter Meersseman, Patrick Verschueren, Thomas Tousseyn, et al.
Rheumatology (Oxford, England)|November 8, 2015
Non-infective endocarditis with systemic embolization and recurrent stroke in systemic sclerosisEllen De Langhe, Alexandra Seghers, Philippe Demaerel, et al.
Clinical Rheumatology|March 7, 2007
Development of sarcoidosis in etanercept-treated rheumatoid arthritis patientsKilian Verschueren, Els Van Essche, Patrick Verschueren, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 20, 2024
Integrating pretest probability for rheumatoid arthritis with likelihood ratios of RF and ACPA to improve clinical utility of rheumatoid arthritis autoantibody testingDaphné Vandebeek, Elke Lodewijckx, Lieve Van Hoovels, et al.
Joint Bone Spine|January 23, 2023
The future of polymyalgia rheumatica research: What can we learn from rheumatoid arthritis?Lien Moreel, Michaël Doumen, Albrecht Betrains, et al.
Clinical and Experimental Rheumatology|December 4, 2013
Anti-TNF therapy and malignancy in spondyloarthritis in the Leuven spondyloarthritis biologics cohort (BIOSPAR)Ine Westhovens, Rik J Lories, Rene Westhovens, et al.
Expert Opinion on Pharmacotherapy|June 11, 2015
The optimal combination therapy for the treatment of early rheumatoid arthritisDiederik De Cock, Kristien Van der Elst, Sabrina Meyfroidt, et al.
Best Practice & Research. Clinical Rheumatology|September 19, 2006
Contemporary concepts of inflammation, damage and repair in rheumatic diseasesFrank P Luyten, Rik J U Lories, Patrick Verschueren, et al.
Clinical Chemistry and Laboratory Medicine|November 15, 2013
Value-added reporting of antinuclear antibody testing by automated indirect immunofluorescence analysisSofie Schouwers, Myriam Bonnet, Patrick Verschueren, et al.
RMD Open|March 13, 2026
Autoantibody biomarkers and first-line therapy response in RA: findings from the CAP48 cohortSukayna Fadlallah, Judith Fraussen, Pieter Ruytinx, et al.
Pageof 16